Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Eprex 2000iu/1mL injection |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Eprex 4000iu/1mL injection |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Epoetin alfa 4000iu/1mL injection |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Oxymetholone 50mg tablet - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Nandrolone decanoate 100mg/1mL oily injection |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Deca-Durabolin 100 oily injection |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Folinic acid 30mg/10mL injection - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Folinic acid 30mg injection (pdr for recon) - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Folinic acid 15mg injection (pdr for recon) - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Folinic acid 3mg/mL injection - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Folinic acid 15mg tablet - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Folinic acid 300mg/30mL injection - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Folinic acid 15mg/2mL injection - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Folinic acid 350mg/35mL injection solution - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Lederfolin 350mg/35mL injection solution |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Calcium Leucovorin 100mg/10mL injection |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Calcium Leucovorin 50mg/5mL injection |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Calcium Leucovorin 15mg/2mL injection |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Calcium Leucovorin 300mg/30mL injection |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Levofolinic acid 50mg/5mL injection - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Sodiofolin 900mg/18mL injection |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Sodiofolin 400mg/8mL injection |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Sodiofolin 100mg/2mL injection |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Folinic acid 900mg/18mL injection - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Folinic acid 400mg/8mL injection - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Folic acid 2.5mg/5mL sugar free syrup - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Preconceive 400micrograms tablet |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Folic acid 400micrograms tablet - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Lexpec 2.5mg/5mL sugar free syrup |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Folic acid 5mg tablet - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Folic acid 100micrograms tablet - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Cyanocobalamin 35micrograms/5mL oral liquid - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Cyanocobalamin 50micrograms tablet - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Cytamen 1mg/1mL injection |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Cytacon 35micrograms/5mL oral liquid |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Cytacon 50micrograms tablet |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Cyanocobalamin 1mg/1mL injection - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Neo-Cytamen 1mg/1mL injection |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Cobalin-H 1mg/1mL injection |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Hydroxocobalamin 1mg/1mL injection - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Venofer 100mg/5mL intravenous solution |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Iron hydroxide sucrose complex 100mg/5mL(Fe) intravenous solution - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Iron sorbitol injection - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Jectofer injection |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Dencyl Spansule |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Ditemic Spansule |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Fortespan Spansule |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Ferrous gluconate+folic acid+ascorbic acid 250mg/5mg/10mg tablet - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Ferric ammonium citrate+folic acid 80mg/2.5mg/5mL syrup - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Ferrous sulphate+folic acid 160mg/400micrograms m/r tablet - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Ferrous fumarate+folic acid 304mg/350micrograms tablet |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Ferric ammonium citrate+folic acid 80mg/500micrograms/5mL syrup - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Ferrous fumarate+folic acid 305mg/350mg capsule - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Ferrous fumarate+folic acid 305mg/400micrograms tablet |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Kloref 500mg effervescent tablet |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Kay-Cee-L 7.5% syrup |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Neupogen Singleject 48million units/0.5mL prefilled syringe |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Neupogen Singleject 30million units/0.5mL prefilled syringe |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Filgrastim 48million units/0.5mL prefilled syringe |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Filgrastim 30million units/0.5mL prefilled syringe |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Neupogen 48million units/1.6mL prefilled syringe |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Neupogen 30million units/1mL prefilled syringe |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Filgrastim 48million units/1.6mL prefilled syringe |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Filgrastim 30million units/1mL prefilled syringe |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Filgrastim 48million units/1.6mL injection - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Filgrastim 30million units/1mL injection - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Epoetin beta 4000iu prefilled syringe - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Epoetin beta 6000iu prefilled syringe - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Epoetin beta 60,000iu injection cartridge - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
NeoRecormon 60,000iu injection cartridge |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
NeoRecormon 6000iu prefilled syringe |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
NeoRecormon 4000iu prefilled syringe |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
NeoRecormon 10,000iu prefilled syringe |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
NeoRecormon 5000iu prefilled syringe |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
NeoRecormon 3000iu prefilled syringe |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
NeoRecormon 2000iu prefilled syringe |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
NeoRecormon 1000iu prefilled syringe |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
NeoRecormon 500iu prefilled syringe |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Epoetin beta 10,000iu prefilled syringe - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Epoetin beta 5000iu prefilled syringe - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Epoetin beta 3000iu prefilled syringe - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Epoetin beta 2000iu prefilled syringe - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Epoetin beta 1000iu prefilled syringe - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
NeoRecormon 500iu injection (pdr for recon)+solvent |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
NeoRecormon 20,000iu injection cartridge |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
NeoRecormon 10,000iu injection cartridge |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Epoetin beta 20,000iu injection cartridge - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Epoetin beta 10,000iu injection cartridge - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
NeoRecormon 100,000iu injection (pdr for recon)+solvent |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
NeoRecormon 50,000iu injection (pdr for recon)+solvent |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Fructose powder - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Epoetin beta 100,000iu injection (pdr for recon)+solvent - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Epoetin beta 50,000iu injection (pdr for recon)+solvent - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Recormon 10,000iu injection+diluent |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Recormon S 10,000iu injection+diluent+syringe |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Recormon S 5000iu injection+diluent+syringe |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Epoetin beta 10,000iu injection+diluent |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Epoetin beta 10,000iu injection+diluent+syringe |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Ferrograd-C Filmtab |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Fefol Z Spansule |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Polysaccharide iron complex capsule |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|